Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter
Donate

Let's beat cancer sooner

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Category: Science blog June 19, 2017 0 comments

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

Read More

News digest – Improving prostate cancer survival, a life-extending app, yoga and… a tribute to Professor Patrick Johnston.

Category: Science blog June 10, 2017 1 comment

Improving prostate cancer survival, a life-extending app, yoga and our tribute to the remarkable Professor Patrick Johnston. Here’s our weekly news report.

Read More

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

Category: Science blog June 6, 2017 20 comments

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

Read More

ASCO 2016: will fine-tuning treatments require redefined tumours?

Category: Science blog June 15, 2016 Comments are closed

From immunotherapy to targeted cancer treatment, here’s our round up of the big news from the annual ASCO conference.

Read More

ASCO 2015 round-up: immunotherapy continues to come of age

Category: Science blog June 5, 2015 1 comment

We take a look back at the excitement from – and add a few important caveats to – the research from this year’s big US cancer conference.

Read More

Don’t take vitamin B3 to prevent skin cancer – stick with shade

Category: Science blog May 15, 2015 2 comments

This morning’s headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story

Read More

New immunotherapy drugs hit the headlines – how do they work?

Category: Science blog June 2, 2014 4 comments

In the light of continued media attention, we explain the science behind two exciting new types of immunotherapy drug, called PD-1 and PD-L1 blockers.

Read More

ASCO 2013 – personalised medicine: potential and challenges

Category: Science blog June 7, 2013 Comments are closed

In our third instalment from the ASCO cancer conference, Debbie Coates writes about a major theme of modern cancer researc...

Read More

ASCO 2013 – clinical trials for older cancer patients

Category: Science blog June 5, 2013 Comments are closed

In our second report from this year’s ASCO conference, Trevor Bott writes about a session he attended on the need for cl...

Read More